Correlation Between Enliven Therapeutics and Lantern Pharma
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Lantern Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Lantern Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Lantern Pharma, you can compare the effects of market volatilities on Enliven Therapeutics and Lantern Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Lantern Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Lantern Pharma.
Diversification Opportunities for Enliven Therapeutics and Lantern Pharma
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Enliven and Lantern is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Lantern Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lantern Pharma and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Lantern Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lantern Pharma has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Lantern Pharma go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Lantern Pharma
Given the investment horizon of 90 days Enliven Therapeutics is expected to under-perform the Lantern Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Enliven Therapeutics is 1.51 times less risky than Lantern Pharma. The stock trades about -0.18 of its potential returns per unit of risk. The Lantern Pharma is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 331.00 in Lantern Pharma on September 2, 2024 and sell it today you would lose (10.00) from holding Lantern Pharma or give up 3.02% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. Lantern Pharma
Performance |
| Timeline |
| Enliven Therapeutics |
| Lantern Pharma |
Enliven Therapeutics and Lantern Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and Lantern Pharma
The main advantage of trading using opposite Enliven Therapeutics and Lantern Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Lantern Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lantern Pharma will offset losses from the drop in Lantern Pharma's long position.| Enliven Therapeutics vs. Crinetics Pharmaceuticals | Enliven Therapeutics vs. Enanta Pharmaceuticals | Enliven Therapeutics vs. Amicus Therapeutics | Enliven Therapeutics vs. Connect Biopharma Holdings |
| Lantern Pharma vs. Tff Pharmaceuticals | Lantern Pharma vs. Eliem Therapeutics | Lantern Pharma vs. Inhibrx | Lantern Pharma vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |